Interictal (n = 16) | Ictal (n = 8) | Healhy control (n = 12) | P—value | |
---|---|---|---|---|
Age | 34.62 (28.66—40.58) | 36.87 (26.93—46.81) | 30.75 (27.95—33.55) | 0.91 |
Body mass index (BMI) | 21.95 (19.84—24.06) | 21.90 (19.59—24.20) | 23.28 (21.39—25.17) | 0.36 |
Last meal (hours ago) | 6.67 (3.65—9.68) | 6.62 (1.64—11.61) | 3.83 (0.66—6.99) | 0.21 |
Co-morbidities and therapy | ||||
Known other diseases (%) | 50 (24—75) | 50 (12—87) | 1.00 | |
Regular medication (except attack therapy) (%) | 31 (7—54) | 38 (1—73) | 0.76 | |
Hormonal contraceptives (%) | 37 (12—62) | 25 (0—57) | 25 (0—51) | 0.73 |
Antimigraine prophylactic therapy (%) | 0 | 0 | ||
Clinical features of the headache | ||||
Disease duration (years) | 13.18 (8.95—17.41) | 15.5 (7.98—23.01) | 0.51 | |
Attack frequency (attack/year) | 23.93 (16.65—31.22) | 21.87 (10.95—32.79) | 0.62 | |
Visual analogue scale category (VAS) | 2.68 (2.45—2.92) | 2.62 (2.26—2.98) | 0.76 | |
Allodynia (%) | 31 (7—54) | 50 (12—87) | 0.38 | |
Chronic pain (%) | 18 (0—38) | 12 (0—37) | 0.70 | |
Menstruation-headache relationship (sensitive) (%) | 37 (12—62) | 37 (1—73) | 1.00 | |
Migraineurs in the family (%) | 68 (0.45—0.92) | 62 (26—98) | 0.76 | |
Regular exercise (%) | 56 (30—81) | 62 (26—98) | 17 (0—39) | 0.06 |
Features of attacks before samplings | ||||
Number of attacks in the previous month | 2.62 (1.4—3.84) | 0.87 (0.18—1.56) | 0.03 | |
Last attack (days ago) | 20.25 (3.26—37.23) | 36.62 (3.38—69.86) | 0.04 | |
Beginning of attack before ictal sampling (hours) | 6.31 (1.24—11.38) | |||
Actual VAS | 5.62 (4.79—6.45) |